Several medical organisations have filed a lawsuit against RFK Jr and the HHS ov...
The pulmonary arterial hypertension market is forecast to grow at a CAGR of 2.0%...
Swissmedic has approved Novartis’ Coartem (artemether-lumefantrine) Baby, descri...
GSK has concluded the acquisition of efimosfermin alfa, an investigational thera...
The FDA has approved Ekterly (sebetralstat) as the first and only oral on-demand...
JCR Pharmaceuticals has signed a licence agreement with Alexion, AstraZeneca Rar...
Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfol...
A discussion on formulation development, contract services, and some of the crit...
The acquisition will bring the Nasdaq-listed Theratechnologies back under privat...
The UK’s Labour Government has revealed its ’10-year plan’ for the country’s Nat...
BioVersys and Shionogi have entered a research and exclusive licence option agre...
Lynozyfic has the potential to be administered monthly, giving it an advantage o...
Data fragmentation slows operations, increases costs, and blocks the ability to ...
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-...
The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is consid...
More than half of the top 15 pharma companies are expected to face challenges in...
